Strategic solutions for cost, time and quality challenges in drug development

In today’s competitive pharmaceutical landscape, successfully advancing a drug candidate from discovery to commercialization requires a strategic balance of cost, time, and quality. Drug developers face a complex array of challenges, from rigorous analytical method development and robust process optimization to manufacturing scale-up, regulatory compliance, and global supply chain management. Each decision along the development pathway can impact timelines, budgets, and ultimately, the quality and safety of the final product.

Join a panel of Cambrex experts for an interactive webinar as they share actionable insights and proven strategies for navigating these critical trade-offs. Drawing on real-world case studies and deep industry expertise, our panel will discuss:

Scientific approaches to risk mitigation in early development, including advanced analytics, robust experimental design, and regulatory foresight to minimize costly setbacks.
Best practices for efficient process transfer and scale-up, leveraging advanced technologies and cross-functional collaboration to accelerate timelines while maintaining product integrity.
Key criteria for selecting the right CDMO partner, focusing on technical capabilities, regulatory track record, and business alignment to ensure successful market entry.

Whether you are a technical leader seeking to optimize your development program or a business professional evaluating strategic investments, this session will provide practical guidance to help you achieve your next milestone—without compromising on quality.

Register now to gain valuable perspectives on how to balance the triple constraint and drive successful outcomes in drug development.

First name

Last name

Company

Job Title

Country

ZIP/Postal Code

What phase of development is your project in?

What are you hoping to learn from this discussion?

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from Endpoints News and/or the sponsor(s). View how we use your data here.

If you are experiencing problems with your registration, please try the Zoom registration page.

Elena Bejan

General Manager, Cambrex Charles City

Dan Bowles

Vice President & General Manager, Cambrex High Point

Dan is a Ph.D. synthetic organic chemist with over 20 years’ experience in drug development and chemical process R&D within the pharmaceutical and CDMO industries. Dan joined the Cambrex High Point site in 2012 and most recently served as Sr. Director Chemical Development before being promoted to Vice President and General Manager of Cambrex’s High Point, North Carolina facility. Over the past 13 years, Dan has helped to create Cambrex High Point’s strong interface between chemistry groups and kilo-lab/pilot plant operations, and had responsibility for the Chemistry, GMP Analytical, and Engineering teams at CHP. Prior to joining Cambrex, Dan served as Senior Principal Scientist at Pfizer R&D.

Derek Koops

Vice President & General Manager, Cambrex Longmont

Derek is an experienced CDMO executive with more than 25 years of experience in pharmaceutical product development. Derek comes from a project management background and has held product development leadership roles at oral solid dose and biologics sites for leading CDMO’s including Cambrex, Thermo Fisher, Patheon and Therapure Biopharma. Prior to joining Cambrex in November 2022, Derek was General Manager of the Thermo Fisher Early Development Site in Bend, Oregon and previously lead the Pharmaceutical Development Services business at Patheon’s site in Whitby, Ontario. Derek earned a M.Sc. in Biochemistry from McGill University and a bachelor’s degree in Biochemistry from Queen’s University.

Moderator

Surani Fernando

Healthcare journalist, writer & podcaster

Surani Fernando is a seasoned healthcare journalist and editor with over 13 years experience covering the biopharma industry. A Sydney native, she started her investigative journalism career in London covering clinical trials, M&A and financing deals for BioPharm Insight, later moving to New York to continue her work as an enterprise journalist and editorial leader for GlobalData and Reorg. She is now based in Madrid working as a freelance journalist, consultant writer and podcast producer. In November 2023, she launched the Raising Biotech podcast.